IP Library › Granted Patent US 12,327,618
Granted Patent B2
US 12,327,618 · App. 18/607,070 · Granted Jun 10, 2025

Systems and methods for tissue sample processing

Inventors: Matthew O. Leavitt (Salt Lake City, UT); Sorin Musat (Bucharest, RO)
Assignee: LEAVITT MEDICAL, INC.
G16H10/40A61B6/5252A61B8/5292B01L3/508G01N1/312G01N35/00029G01N35/00732G01N35/00871G16H10/60G16H30/40G16H50/20G16H80/00H04M17/307B01L2300/021B01L2300/12G01N2035/00772G01N2035/00831G01N2035/00851G01N2035/00881
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,327,618
App. No.
18/607,070
Granted
Jun 10, 2025
Kind
B2
Abstract

Tissue sample management systems include a central network, a medical professional system, and a pathology lab system for processing a tissue sample in a matrix having a sectionable code. At least the pathology lab system includes at least one imaging device, and the central network is configured to process images from the at least one imaging device to identify and record at least the sectionable code of the matrix. Methods for tissue sample processing include providing a matrix having a sectionable code and measurement marks, the matrix for receiving a tissue sample, and identifying the sectionable code from an image taken of the tissue sample in the matrix. Tissue sample-receiving matrices include a sectionable alphanumeric code or bar code, a tissue sample receptacle, and measurement marks formed along a sidewall thereof. The matrices include one or more proteins and one or more lipids.

Claims (24)

1. A method for tissue sample processing, comprising:

providing a matrix for receiving a tissue sample, wherein the matrix has a sectionable code and

measurement marks positioned in the matrix at predetermined initial intervals, and wherein the matrix is configured to exhibit a shrinkage rate substantially the same as a shrinkage rate of the tissue sample when subjected to a pathological process; taking a first image of the tissue sample in the matrix; transmitting the first image to a central network including at least a processor and a database;

wherein the processor is programmed to process images of the tissue sample and matrix so as to one or more of: interpret measurement marks, distinguish between the tissue sample and adjacent portions of the matrix, measure features of the tissue sample, or identify the sectionable code in the matrix;

and wherein the processor further is programmed to correlate the tissue sample and images thereof with a particular sectionable code in the corresponding matrix, for digitally registering the matrix and the tissue sample and correlating the matrix and the tissue sample to a patient from which the tissue sample was obtained and wherein said processor is programmed through machine learning;

identifying, from the first image, the sectionable code with the processor;

digitally storing the sectionable code in the database; correlating the stored sectionable code with identification information of a patient from which the tissue sample was obtained;

taking a second image of the tissue sample in the matrix having the sectionable code and measurement marks after at least some pathological processing;

transmitting the second image to the central network;

identifying, from the second image, the sectionable code with the processor;

identifying, from the second image, the measurement marks with the processor; and

correlating the second image with the identification information of the patient from which the tissue sample was obtained.

2. The method of claim 1 , wherein the processor is further programmed to process the images of the tissue sample so as to identify depth gauges, further comprising identifying, from the second image, a depth gauge of the matrix with the processor.

3. A tissue sample-receiving matrix, comprising:

a sectionable machine-readable barcode;

at least one tissue sample receptacle; and

measurement marks formed at predetermined initial intervals along at least one sidewall of the at least one tissue sample receptacle,

wherein the tissue sample-receiving matrix comprises a material comprising one or more proteins and one or more lipids.

4. The tissue sample-receiving matrix of claim 3 , further comprising at least one depth gauge.

5. The tissue sample-receiving matrix of claim 4 , wherein the depth gauge comprises an angled surface of the tissue sample-receiving matrix.

6. The tissue sample-receiving matrix of claim 3 , wherein the measurement marks are formed at predetermined initial intervals of between 1 mm and 0.25 inch.

7. The method of claim 1 , wherein the measurement marks are at predetermined initial intervals of between 1 mm and 0.25 inch.

8. The method of claim 1 , wherein the processor is further programmed to process the images of the tissue sample so as to identify and locate cellular material of interest in the tissue sample.

9. The method of claim 1 , wherein the processor is further programmed to process the images of the tissue sample so as to determine a percent involvement of identified abnormal cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2024
From: LEAVITT, MATTHEW O.; MUSAT, SORIN
To: LEAVITT MEDICAL, INC.
Reel/Frame 066910/0922 →
Continuity (5)
Division 16984134 · Aug 3, 2020
Division 15893061 · Feb 9, 2018
Provisional Application 62556910 · Sep 11, 2017
Provisional Application 62457078 · Feb 9, 2017
Related Publication 20240221876A1 · Jul 4, 2024
References Cited (26)
US 5817032A · Williamson, IV · 1998 [cited by applicant]
US 6246785B1 · Molnar · 2001 [cited by applicant]
US 7156814B1 · Williamson, IV · 2007 [cited by applicant]
US 8463741B2 · Ehlke · 2013 [cited by applicant]
US 10734100B2 · Leavitt · 2020 [cited by applicant]
US 20090226065A1 · Chen · 2009 [cited by applicant]
US 20100167334A1 · Williamson, IV · 2010 [cited by applicant]
US 20110125526A1 · Gustafson · 2011 [cited by applicant]
US 20120329140A1 · Iqbal · 2012 [cited by applicant]
US 20140073004A1 · Williamson, IV · 2014 [cited by applicant]
US 20140135236A1 · Musat · 2014 [cited by applicant]
US 20140273063A1 · Baust · 2014 [cited by applicant]
US 20160085913A1 · Evans · 2016 [cited by applicant]
CA 3052203A1 · 2018 [cited by applicant]
CN 110431637A · 2019 [cited by applicant]
WO WO2014130592A1 · 2014 [cited by examiner]
WO WO2016013949A2 · 2016 [cited by examiner]
WO 2018148548A1 · 2018 [cited by applicant]
“Themis Biopsy Chip,” Advertising circular, Themis Biopsy Chip, Version 1.7, Feb. 2016, 2 pages. [cited by applicant]
International Preliminary Report on Patentability received for PCT Application No. PCT/US2018/017628 dated Aug. 22, 2019, 9 pages. [cited by applicant]
International Search Report received for PCT Application No. PCT/US2018/017628 dated May 23, 2018, 3 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 15/893,061 dated Mar. 6, 2020, 32 pages. [cited by applicant]
Notice of Allowance received for U.S. Appl. No. 15/893,061 dated Jun. 22, 2020, 52 pages. [cited by applicant]
Written Opinion received for PCT Application No. PCT/US2018/017628 dated May 23, 2018, 7 pages. [cited by applicant]
Ciaran Cunniffe, The Role of Aperio GENIE Image Analysis Tool in Modern Histopathology, The Pathology Company—Leica BioSystems, 2015; 4 pages. [cited by applicant]
Neeraj Sharma et al., Segmentation and classification of medical images using texture-primitive features: Application of BAM-type artificial neural network, Journal of Medical Physics, vol. 33, No. 3, 2008, p. 119-126, … [cited by applicant]